Author(s): Kurman RJ, Shih IeM
The recent 2014 World Health Organization (WHO) Classification of Tumours of the Female Reproductive Organs introduced a new category of ovarian neoplasm designated "seromucinous tumours". The recognition of this distinctive group of tumors is an important addition to the classification but the term "seromucinous" has serious flaws that obscures the nature of these neoplasms. Morphologically, seromucinous tumors in addition to serous and endocervical-type mucinous epithelium, contain endometrioid, indifferent and squamous type epithelium. Their immunoprofile is characterized by frequent expression of ER, PR, infrequent expression of WT1 and lack of expression of CK20 and CDX2, an immunostaining pattern consistent with a "müllerian" immunophenotype. Unlike serous and intestinal type mucinous tumors, seromucinous tumors are frequently associated with endometriosis making them more analogous to endometrioid and clear cell neoplasms. Indeed, recent studies have shown that a high proportion of seromucinous tumors lost expression of ARID1A, a tumor suppressor gene, that is mutated in approximately 50% of endometrioid and clear cell tumors, in sharp contrast to serous and intestinal-type mucinous tumors which do not contain ARID1A mutations or lose its expression. Therefore, based on their clinicopathologic, immunohistochemical and molecular genetic features we believe a more appropriate designation for this group of tumors is "mixed müllerian tumors" which can be subcategorized as "mixed müllerian cystadenomas", "mixed müllerian atypical proliferative (borderline) tumors" and "mixed müllerian carcinomas".
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/26598986
Author(s): Kurman RJ, Norris HJ
Author(s): Lacey JV Jr, Ioffe OB, Ronnett BM, Rush BB, Richesson DA, et al.
Author(s): Reed SD, Newton KM, Clinton WL, Epplein M, Garcia R, et al.
Author(s): Lacey JV Jr, Sherman ME, Rush BB, Ronnett BM, Ioffe OB, et al.
Author(s): Ferenczy A
Author(s): Stein CJ, Colditz GA
Author(s): Reed SD, Newton KM, Garcia RL, Allison KH, Voigt LF, et al.
Author(s): Ricci E, Moroni S, Parazzini F, Surace M, Benzi G, et al.
Author(s): Bobrowska K, Kamiński P, Cyganek A, Pietrzak B, Jabiry-Zieniewicz Z, et al.
Author(s): Heller DS, Mosquera C, Goldsmith LT, Cracchiolo B
Author(s): Gregoriou O, Konidaris S, Vrachnis N, Bakalianou K, Salakos N, et al.
Author(s): DerSimonian R, Kacker R
Author(s): Higgins JP, Thompson SG, Deeks JJ, Altman DG
Author(s): Higgins JP, Thompson SG
Author(s): Egger M, Davey Smith G, Schneider M, Minder C
Author(s): Epplein M, Reed SD, Voigt LF, Newton KM, Holt VL, et al.
Author(s): Cheung AP
Author(s): Viola AS, Gouveia D, Andrade L, Aldrighi JM, Viola CF, et al.
Author(s): Kreiger N, Marrett LD, Clarke EA, Hilditch S, Woolever CA
Author(s): Weir HK, Sloan M, Kreiger N
Author(s): Epplein M, Reed SD, Voigt LF, Newton KM, Holt VL, et al.
Author(s): Nagamani M, Urban RJ
Author(s): Al-Jarrah M, Matalka I, Aseri HA, Mohtaseb A, Smirnova IV, et al.
Author(s): Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, et al.
Author(s): Tankó LB, Christiansen C
Author(s): Midgette AS, Baron JA
Author(s): Cramer DW, Barbieri RL, Muto MG, Kelly A, Brucks JP, et al.
Author(s): Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, et al.
Author(s): Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, et al.
Author(s): Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, et al.
Author(s): Thune I, Furberg AS
Author(s): Schonfeld SJ, Hartge P, Pfeiffer RM, Freedman DM, Greenlee RT, et al.
Author(s): Benshushan A, Paltiel O, Rojansky N, Brzezinski A, Laufer N
Author(s): Parslov M, Lidegaard O, Klintorp S, Pedersen B, Jønsson L, et al.
Author(s): Kelsey JL, LiVolsi VA, Holford TR, Fischer DB, Mostow ED, et al.
Author(s): Elwood JM, Cole P, Rothman KJ, Kaplan SD
Author(s): Parazzini F, La Vecchia C, Moroni S, Chatenoud L, Ricci E